Compugen Q4 EPS $0.11 Misses $0.23 Estimate, Sales $33.46M Beat $20.00M Estimate
Portfolio Pulse from Benzinga Newsdesk
Compugen (NASDAQ:CGEN) reported Q4 earnings of $0.11 per share, missing the $0.23 estimate, but saw sales of $33.46M, beating the $20.00M estimate. This represents a significant increase from the previous year's losses and sales figures.
March 05, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Compugen's Q4 earnings per share missed estimates, but sales significantly exceeded expectations, showing strong revenue growth.
While the earnings per share (EPS) missed the analyst consensus, the substantial beat on sales and the significant year-over-year growth in both earnings and sales could be seen positively by investors. The mixed results (miss on EPS but beat on sales) may lead to neutral short-term price movement as investors weigh the implications.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100